155 related articles for article (PubMed ID: 23110658)
1. Does limited virucidal activity of biocides include duck hepatitis B virucidal action?
Sauerbrei A; Schacke M; Glück B; Bust U; Rabenau HF; Wutzler P
BMC Infect Dis; 2012 Oct; 12():276. PubMed ID: 23110658
[TBL] [Abstract][Full Text] [Related]
2. Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants?
Rabenau HF; Rapp I; Steinmann J
BMC Infect Dis; 2010 Jun; 10():185. PubMed ID: 20573218
[TBL] [Abstract][Full Text] [Related]
3. Validation of biocides against duck hepatitis B virus as a surrogate virus for human hepatitis B virus.
Sauerbrei A; Schacke M; Glück B; Egerer R; Wutzler P
J Hosp Infect; 2006 Dec; 64(4):358-65. PubMed ID: 17011665
[TBL] [Abstract][Full Text] [Related]
4. Is hepatitis B-virucidal validation of biocides possible with the use of surrogates?
Sauerbrei A
World J Gastroenterol; 2014 Jan; 20(2):436-44. PubMed ID: 24574712
[TBL] [Abstract][Full Text] [Related]
5. Substitution of vaccinia virus Elstree by modified vaccinia virus Ankara to test the virucidal efficacy of chemical disinfectants.
Hartnack S; Essbauer S; Truyen U
Zoonoses Public Health; 2008; 55(2):99-105. PubMed ID: 18234028
[TBL] [Abstract][Full Text] [Related]
6. Development of viral disinfectant assays for duck hepatitis B virus using cell culture/PCR.
Wang CY; Giambrone JJ; Smith BF
J Virol Methods; 2002 Oct; 106(1):39-50. PubMed ID: 12367728
[TBL] [Abstract][Full Text] [Related]
7. Chemical disinfection of duck hepatitis B virus: a model for inactivation of infectivity of hepatitis B virus.
Tsiquaye KN; Barnard J
J Antimicrob Chemother; 1993 Aug; 32(2):313-23. PubMed ID: 8226434
[TBL] [Abstract][Full Text] [Related]
8. Tungsten carbide nanoparticles show a broad spectrum virucidal activity against enveloped and nonenveloped model viruses using a guideline-standardized in vitro test.
Pfaff F; Glück B; Hoyer T; Rohländer D; Sauerbrei A; Zell R
Lett Appl Microbiol; 2019 Oct; 69(4):302-309. PubMed ID: 31436888
[TBL] [Abstract][Full Text] [Related]
9. Duck hepatitis B virus: a model to assess efficacy of disinfectants against hepadnavirus infectivity.
Murray SM; Freiman JS; Vickery K; Lim D; Cossart YE; Whiteley RK
Epidemiol Infect; 1991 Jun; 106(3):435-43. PubMed ID: 1904824
[TBL] [Abstract][Full Text] [Related]
10. Testing virucidal activity in Germany: an update.
Steinmann J; Wolff MH
GMS Krankenhhyg Interdiszip; 2007 Sep; 2(1):Doc04. PubMed ID: 20200665
[TBL] [Abstract][Full Text] [Related]
11. Povidone-iodine hand wash and hand rub products demonstrated excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses.
Eggers M; Eickmann M; Kowalski K; Zorn J; Reimer K
BMC Infect Dis; 2015 Sep; 15():375. PubMed ID: 26381737
[TBL] [Abstract][Full Text] [Related]
12. Virucidal activity of ortho-phthalaldehyde solutions against hepatitis B and C viruses.
Roberts CG; Chan-Myers HB; Favero MS
Am J Infect Control; 2008 Apr; 36(3):223-6. PubMed ID: 18371520
[TBL] [Abstract][Full Text] [Related]
13. Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.
Yokota T; Konno K; Chonan E; Mochizuki S; Kojima K; Shigeta S; de Clercq E
Antimicrob Agents Chemother; 1990 Jul; 34(7):1326-30. PubMed ID: 2201250
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cell culture systems for duck hepatitis B virus using SyBr green quantitative PCR.
Wang CY; Giambrone JJ; Smith BF
J Virol Methods; 2002 Dec; 106(2):175-84. PubMed ID: 12393148
[TBL] [Abstract][Full Text] [Related]
15. In vitro cultivation and cryopreservation of duck embryonic hepatocytes.
Schacke M; Glück B; Wutzler P; Sauerbrei A
J Virol Methods; 2009 Apr; 157(1):25-31. PubMed ID: 19124040
[TBL] [Abstract][Full Text] [Related]
16. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P
J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155
[TBL] [Abstract][Full Text] [Related]
17. Surface-Dried Viruses Can Resist Glucoprotamin-Based Disinfection.
Zeitler B; Rapp I
Appl Environ Microbiol; 2014 Dec; 80(23):7169-75. PubMed ID: 25217017
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human and duck hepatitis B virus by 2',3'-dideoxy-3'-fluoroguanosine in vitro.
Schröder I; Holmgren B; Oberg M; Löfgren B
Antiviral Res; 1998 Jan; 37(1):57-66. PubMed ID: 9497073
[TBL] [Abstract][Full Text] [Related]
19. Surrogate viruses for testing virucidal efficacy of chemical disinfectants.
Steinmann J
J Hosp Infect; 2004 Apr; 56 Suppl 2():S49-54. PubMed ID: 15110123
[TBL] [Abstract][Full Text] [Related]
20. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
